Hisashi Yamanaka

29.2k total citations · 1 hit paper
739 papers, 17.7k citations indexed

About

Hisashi Yamanaka is a scholar working on Rheumatology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hisashi Yamanaka has authored 739 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 417 papers in Rheumatology, 140 papers in Pathology and Forensic Medicine and 113 papers in Molecular Biology. Recurrent topics in Hisashi Yamanaka's work include Rheumatoid Arthritis Research and Therapies (314 papers), Systemic Lupus Erythematosus Research (148 papers) and Chronic Lymphocytic Leukemia Research (103 papers). Hisashi Yamanaka is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (314 papers), Systemic Lupus Erythematosus Research (148 papers) and Chronic Lymphocytic Leukemia Research (103 papers). Hisashi Yamanaka collaborates with scholars based in Japan, United States and Czechia. Hisashi Yamanaka's co-authors include Naoyuki Kamatani, Atsuo Taniguchi, Eisuke Inoue, Tsutomu Takeuchi, Shigeki Momohara, Yoshiya Tanaka, Taisuke Tomatsu, Eiichi Tanaka, Ayako Nakajima and Yasushi Kawaguchi and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hisashi Yamanaka

714 papers receiving 17.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with aδ/c‐fibers and colocalization with trk receptors

2005 592 citations Hisashi Yamanaka et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hisashi Yamanaka Japan	63	9.5k	2.7k	2.7k	2.6k	2.5k	739	17.7k
Andrea Doria Italy	75	10.3k 1.1×	7.0k 2.5×	2.4k 0.9×	3.1k 1.2×	1.6k 0.6×	515	17.9k
Guido Valesini Italy	64	8.2k 0.9×	4.4k 1.6×	2.3k 0.9×	1.6k 0.6×	2.7k 1.1×	561	16.3k
Miguel Á. González‐Gay Spain	81	13.5k 1.4×	6.3k 2.3×	3.8k 1.4×	2.9k 1.1×	1.9k 0.7×	799	25.0k
Stefano Bombardieri Italy	65	6.4k 0.7×	5.1k 1.9×	2.2k 0.8×	1.8k 0.7×	1.2k 0.5×	448	16.2k
Naoyuki Kamatani Japan	58	4.4k 0.5×	2.5k 0.9×	5.3k 2.0×	1.5k 0.6×	1.3k 0.5×	344	13.5k
Dimitrios T. Boumpas Greece	69	7.3k 0.8×	7.4k 2.7×	2.6k 0.9×	1.6k 0.6×	1.4k 0.6×	317	15.5k
Juan J. Gómez‐Reino Spain	72	10.7k 1.1×	5.3k 1.9×	2.5k 0.9×	4.0k 1.5×	3.8k 1.5×	364	19.8k
Frederick W. Miller United States	76	5.9k 0.6×	4.0k 1.5×	4.6k 1.7×	9.6k 3.7×	1.9k 0.7×	436	19.7k
Pier Luigi Meroni Italy	81	18.0k 1.9×	9.0k 3.3×	2.6k 1.0×	2.3k 0.9×	7.6k 3.0×	621	28.6k
Yoshiya Tanaka Japan	80	14.5k 1.5×	9.6k 3.5×	5.7k 2.1×	2.5k 0.9×	5.2k 2.1×	1.1k	30.4k

Countries citing papers authored by Hisashi Yamanaka

Since Specialization

Citations

This map shows the geographic impact of Hisashi Yamanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisashi Yamanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisashi Yamanaka more than expected).

Fields of papers citing papers by Hisashi Yamanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisashi Yamanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisashi Yamanaka. The network helps show where Hisashi Yamanaka may publish in the future.

Co-authorship network of co-authors of Hisashi Yamanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hisashi Yamanaka. A scholar is included among the top collaborators of Hisashi Yamanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisashi Yamanaka. Hisashi Yamanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Eiichi, Eisuke Inoue, Rei Yamaguchi, et al.. (2023). Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort. Modern Rheumatology. 34(2). 322–328. 1 indexed citations

Takeuchi, Tsutomu, Kiyohiro Nishikawa, Akimichi Morita, et al.. (2023). Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies. Drug Safety. 46(10). 991–1005. 3 indexed citations

Furuya, Takefumi, Eisuke Inoue, Eiichi Tanaka, et al.. (2023). Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Clinical Rheumatology. 43(1). 521–526. 9 indexed citations

Tanaka, Eiichi, Eisuke Inoue, Ayako Shoji, et al.. (2022). Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. PLoS ONE. 17(11). e0277566–e0277566. 3 indexed citations

Tanaka, Yoshiya, Satoshi Soen, Naoki Ishiguro, et al.. (2020). Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction. RMD Open. 6(2). e001249–e001249. 7 indexed citations

Furuya, Takefumi, Eisuke Inoue, Eiichi Tanaka, et al.. (2020). Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study. SHILAP Revista de lepidopterología. 6(2). 82–87. 6 indexed citations

Kishi, Takayuki, Takako Miyamae, Manabu Kawamoto, et al.. (2020). The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis. Clinical Rheumatology. 39(3). 841–845. 3 indexed citations

Tanaka, Yoshiya, et al.. (2018). Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T). Modern Rheumatology. 29(2). 306–313. 3 indexed citations

Takeuchi, Tsutomu, Yoshiya Tanaka, Naoki Ishiguro, et al.. (2016). Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Annals of the Rheumatic Diseases. 75(6). 983–990. 131 indexed citations

10.

Atsumi, Tatsuya, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.. (2015). The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Annals of the Rheumatic Diseases. 75(1). 75–83. 84 indexed citations

11.

Hoshi, Daisuke, Ayako Nakajima, Kumi Shidara, et al.. (2013). Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab. Modern Rheumatology. 23(6). 1205–10. 9 indexed citations

12.

Momohara, Shigeki, Eisuke Inoue, Katsunori Ikari, et al.. (2011). Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life. Modern Rheumatology. 21(5). 476–481. 23 indexed citations

13.

Furuya, Takefumi, et al.. (2009). Associated factors for falls and fear of falling in Japanese patients with rheumatoid arthritis. Clinical Rheumatology. 28(11). 1325–1330. 59 indexed citations

14.

Tsukahara, S., Minoru Shinozaki, Katsunori Ikari, et al.. (2007). Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients. Lara D. Veeken. 47(1). 41–44. 19 indexed citations

15.

Taniguchi, Atsuo, Masayuki Hakoda, Hisashi Yamanaka, et al.. (1998). A germline mutation abolishing the original stop codon of the human adenine phosphoribosyltransferase (APRT) gene leads to complete loss of the enzyme protein. Human Genetics. 102(2). 197–202. 13 indexed citations

16.

Fujimori, Shin, et al.. (1996). An asymptomatic germline missense base substitution in the hypoxanthine phosphoribosyltransferase (HPRT) gene that reduces the amount of enzyme in humans. Human Genetics. 99(1). 8–10. 8 indexed citations

17.

Suzuki, Kazuo, Genju Ooneda, Hisashi Yamanaka, et al.. (1990). Effect of 17β-estradiol on aortic media of male rats. 23(4). 483–491. 1 indexed citations

18.

Penning, C A, Hisashi Yamanaka, Dennis A. Carson, et al.. (1987). The effect of in vitro neuropeptides np on systemic lupus erythematosus sle lymphocytic mitogen responses and natural killer nk activity. Clinical research. 35(3). 566. 1 indexed citations

19.

Honda, Haruo, et al.. (1978). Excretion of mercury from fish.. Bulletin of the Japanese Society of Scientific Fisheries. 1 indexed citations

20.

Yamanaka, Hisashi. (1974). Orange discolored meat of canned skipjack-III.Changes in amounts of glycolytic intermediates in skipjack meat during thawing and cooking.. 40. 941–947. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact